Consensus ASLAN Pharmaceuticals Limited

Equities

ASLN

US04522R2004

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
0.4198 ^USD	+4.30%		-8.72%	-19.59%

May. 08	Asian Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Wednesday Trading	MT
May. 07	Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading	MT

Evolution of the average Target Price on ASLAN Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

5cd273a389a95750620f2f69a2ac6191.X_4WSymdipCpKEj_UzFYOLpUO7KK5HOWZ65evwFqADU.Zs1yLGPQ_9PjfhvLAQU7SM0FbtvQrSrmVPdq2G0FTAwQoUR8UP_s1-5wOw~39146b46fe7549a637e8e4985b30dc56

Analyst Recommendations on ASLAN Pharmaceuticals Limited

HC Wainwright Cuts ASLAN Pharmaceuticals Price Target to $9 From $17, Maintains Buy Rating	Mar. 18	MT
Piper Sandler Cuts ASLAN Pharmaceuticals' Price Target to $10 From $15, Maintains Overweight Rating	Mar. 13	MT
Roth MKM Initiates ASLAN Pharmaceuticals at Buy With $15 Price Target	23-05-31	MT
Piper Sandler Adjusts Price Target on ASLAN Pharmaceuticals to $3 From $4, Maintains Overweight Rating	23-02-27	MT
HC Wainwright Adjusts Price Target on ASLAN Pharmaceuticals to $4.50 From $7, Keeps Buy Rating	23-02-27	MT
Piper Sandler Adjusts Price Target on ASLAN Pharmaceuticals to $4 From $3, Reiterates Overweight Rating	22-09-16	MT
Piper Sandler Adjusts ASLAN Pharmaceuticals' Price Target to $3 from $8, Keeps Overweight Rating	22-05-23	MT
ASLAN PHARMACEUTICALS : Jefferies & Co Initiates Coverage on ASLAN Pharmaceuticals With Buy Rating, $8 Price Target	21-07-09	MT
ASLAN PHARMACEUTICALS : HC Wainwright Adjusts ASLAN Pharmaceuticals' Price Target to $8 from $5, Keeps Buy Rating	21-03-17	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.4025 USD

Average target price

9.5 USD

Spread / Average Target

+2,260.25%

High Price Target

10 USD

Spread / Highest target

+2,384.47%

Low Price Target

9 USD

Spread / Lowest Target

+2,136.02%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ASLAN Pharmaceuticals Limited

HC Wainwright
Piper Sandler
Roth MKM
Jefferies & Co.

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar